SFORZA, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 1.362
EU - Europa 464
AS - Asia 164
AF - Africa 2
Totale 1.992
Nazione #
US - Stati Uniti d'America 1.361
PL - Polonia 148
CN - Cina 119
IT - Italia 111
UA - Ucraina 73
GB - Regno Unito 49
DE - Germania 39
TR - Turchia 38
FI - Finlandia 18
SE - Svezia 13
BE - Belgio 11
IR - Iran 3
TN - Tunisia 2
VN - Vietnam 2
CA - Canada 1
FR - Francia 1
IN - India 1
JP - Giappone 1
RO - Romania 1
Totale 1.992
Città #
Fairfield 199
Ann Arbor 180
Warsaw 148
Woodbridge 142
Houston 122
Chandler 96
Jacksonville 95
Ashburn 93
Cambridge 76
Ferrara 70
Seattle 61
Wilmington 61
Beijing 43
Izmir 25
Nanjing 19
Princeton 19
San Diego 18
Milan 17
Boardman 13
Shanghai 12
Brussels 11
Mountain View 8
Nanchang 8
Shenyang 8
Addison 6
Changsha 6
Hebei 6
Redwood City 6
Jiaxing 5
Bremen 4
Cagliari 4
London 4
New York 4
Ardabil 3
Kunming 3
Los Angeles 3
Modena 3
Tianjin 3
Dearborn 2
Dong Ket 2
Falls Church 2
Guangzhou 2
Indiana 2
Jinan 2
Leawood 2
Rome 2
San Mateo 2
Auburn Hills 1
Augusta 1
Bologna 1
Camerino 1
Chiswick 1
Farmville 1
Fuzhou 1
Helsinki 1
La Canada Flintridge 1
Lanzhou 1
Montréal 1
New Bedfont 1
Norwalk 1
Orange 1
Osimo 1
Prescot 1
Redmond 1
San Francisco 1
Taranto 1
Tokyo 1
Yellow Springs 1
Totale 1.643
Nome #
The HIV-Tat protein favors the activation of T lymphocytes. Implications for new therapeutic strategies against HIV and other viral infections 173
Effects of different routes of administration on the immunogenicity of the Tat protein and a Tat-derived peptide 146
The HIV-1 Tat protein affects human CD4+ T cell programming and activation, and favors the differentiation of naïve CD4+ T cells 125
Synthesis and biological evaluation of diastereoisomerically pure N,O-nucleosides 124
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: production, characterization and in vitro studies 121
Synthesis, characterization and antiproliferative activity of three platinum(II) complexes of L-​carnitine. The first structural determination of a platinum complex containing carnitine 118
Acetylcholine-like and Trimethylglycine-like PTA (1,3,5-Triaza-7-phosphaadamantane) Derivatives for the Development of Innovative Ru- and Pt-Based Therapeutic Agents 108
null 107
null 106
Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides 106
UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion 105
Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells 101
Platinum and ruthenium complexes of new long-tail derivatives of PTA (1,3,5-triaza-7-phosphaadamantane): Synthesis, characterization and antiproliferative activity on human tumoral cell lines 99
Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors. 99
Different expression of Blimp-1 in HIV infection may be used to monitor disease progression and provide a clue to reduce immune activation and viral reservoirs 98
Unexpected One-Pot Synthesis of Highly Conjugated Pentacyclic Diquinoid Compounds 84
New PTA (1,3,5-triaza 7-phosphaadamantane) derivatives associating zwitterionic structure and coordinativa ability 82
Modified N,O-nucleosides: design, synthesis and evaluation of the antitumor activity 53
null 43
Synthesis and in vitro cytotoxicity of deoxyadenosine-​bile acid conjugates linked with 1,​2,​3-​triazole 20
HIV-1 Tat affects the programming and functionality of human CD8⁺ T cells by modulating the expression of T-box transcription factors 14
Totale 2.032
Categoria #
all - tutte 6.222
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.222


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019228 0 0 0 0 0 0 0 0 0 59 76 93
2019/2020516 78 22 21 71 35 55 46 48 43 47 36 14
2020/2021337 33 26 12 34 13 32 16 42 20 58 40 11
2021/2022226 9 20 23 11 5 9 21 11 13 17 25 62
2022/2023217 23 6 13 35 29 26 17 23 27 1 11 6
2023/202480 9 19 4 0 6 22 4 12 2 2 0 0
Totale 2.032